Business - The Purbottar

22 Jul

OnePlus Nord is the company’s cheapest phone in 2020, launches at Rs 24,999; Buds at Rs 4,990.

editor0 CommentsBusiness

OnePlus has launched its ‘affordable’ Nord smartphone via an AR launch event on July 21, Tuesday. The OnePlus Nord starts at Rs 24,999 for the base 6GB RAM/64GB variant, which will be made available in September. The 8GB RAM/128GB storage and 12GB RAM/256GB storage variants priced at Rs 27,999 and Rs 29,999, respectively, will be made available starting August 4 via Amazon and company’s own website. OnePlus Nord will be available on nord.oneplus.com beginning August 4 in Europe and India. Fifty North American users will have a chance to experience the OnePlus Nord through a limited beta program. Prior to…

22 Jul

Piaggio’s Vespa Facelift Range

editor0 CommentsBusinessVespa

Piaggio India had unveiled two new offerings at Auto Expo 2020 in Greater Noida at the starting of the year and recently commenced the pre-booking of Vespa VXL, SXL Facelift 2020 models with 125 cc and 150 cc BS6 engines. Now, the company launched these two new offerings in the market - the iconic Vespa VXL, SXL Facelift 2020 Range and the sporty new Aprilia Storm with disc brake and digital cluster. Customers can book their choice of new Vespa among the range of models showcased online on Vespa’s e-commerce platform and book the new Aprilia Storm scooter on the…

22 Jul

Hyundai Venue iMT & New ‘Sport Trim’ Launched In India.

editor0 CommentsBusiness

Monsoons in Guwahati have a unique feel, especially en route to Shillong. Cloud-draped sky on the backdrop and driving around the twisties, Hyundai Motor India introduced us to the Venue SUV in May last year.The sub-compact SUV, aimed to take a potshot at the popular Maruti Suzuki Vitara Brezza, came with multiple powertrains, several feel-good features, which were in themselves segment-defining. A year down the line, Hyundai Venue has carved a following, clocking over one lakh sales in the period. The 62 per cent of Venue customers have preferred the petrol variants of the smallest SUV in Hyundai’s line-up. Prices…

22 Jul

Reliance-Google Smartphone Deal Threatens Chinese Firms’

editor0 CommentsBusinessGoogle, Reliance

A $4.5 billion deal under which Alphabet's Google will collaborate with Reliance Industries on a new smartphone likely heralds a big shake-up for the world's second-largest mobile market, industry executives and analysts say. Reliance boss Mukesh Ambani, announcing the partnership at his company's annual meeting last week, said Google would build an Android operating system (OS) to power a low-cost "4G or even 5G" smartphone that Reliance would design. The new phone is set to pose a major challenge to Chinese vendors such as Xiaomi and BBK Electronics, owner of the Realme, Oppo and Vivo brands, which currently dominate a $2 billion market…

22 Jul

HP launches Powerhouse Gaming Portfolio

editor0 CommentsBusinessGaming, Hp

Designed for today’s gamers to play their best while pushing the limits of what their devices can do, HP launched new OMEN Laptops and accessories, updates to OMEN Command Centre. HP also introduced the first 16” Pavilion Gaming Laptop. It offers ‘First of its kind’ hardware technologies in the industry enabling Gameplay experience to next level and offer unmatched power without any compromise. The new HP gaming portfolio and accessories are available at all HP World stores and online (store.hp.com/in). Gaming benefits are being unlocked as people are spending more time at home, uncovering new avenues for both entertainment and…

22 Jul

Glenmark’s response

editor0 CommentsBusiness, HealthGkenmark

In response to a letter regarding representation by a Member of Parliament, Mr Anurag Khera (Sr. Vice-president-Corporate Affairs) of Glenmark pharmaceuticals Limited sent a letter to Dr VG Somani, Director General of Health Services, Central Drugs Standard Control Organisation, clarifying its stand on the product Favipiravir tablets (200mg) manufactured and marketed by Glenmark that was granted permission by the latter’s office. Glenmark said, compared to other therapies approved for emergency use in COVID-19, Favipiravir (FabiFlu) is much more economical and an effective treatment option. The estimated total cost of therapy for full course with Favipiravir is Rs 9150, while Remdesivir,…

22 Jul

Almonds are a preferred snack

editor0 CommentsBusiness, HealthAlmomds

In today's fast-paced world, snacking has become an integral part of many Indians daily diet and routine. According to a recent survey conducted across 11 cities in India between 3 to 24 March by IPSOS, a research consulting firm, 91% of the participants try and opt for healthier alternatives whilst snacking. The survey by IPSOS aimed to identify the snacking habits and preferences amongst a group of people whose dietary preferences were divided into two categories - ‘vegetarian and non- vegetarian’. Overall, the results indicate that the participants across both categories prefer to snack on healthy and nutritious food items…

21 Jul

SsangYong E100 (Tivoli EV) electric SUV teased.

editor0 CommentsBusiness

Mahindra-backed Korean carmaker SsangYong revealed teaser images of E100 (Tivoli EV), which is likely to make for eXUV300 in India.M&M showcased the concept of eXUV300 electric SUV at the Auto Expo. SsangYong Tivoli, sold in the global market, shares its same platform with XUV300. The electric subcompact SUV is scheduled to be launched in the first half of 2021. Mahindra had also informed a similar timeline for the launch of eXUV300. The overall design is based on a streamlined line that reflects aerodynamics optimized for urban driving. Aluminum hood was applied to lighten weight and optimize the center of gravity…

21 Jul

N-95 masks with respirators don’t anticipate COVID-19 transmission, warns govt

editor0 CommentsBusinessCovid-19, N-95

The Centre has written to all states and union territories warning against the use of N-95 face masks with valved respirators saying they don't prevent coronavirus transmission. Calling these masks "detrimental", the government has sought measures to contain the coronavirus spread. The letter written by the Director-General of Health Services (DGHS) in the Health Ministry to the principal secretaries of health and medical education of states and UTs states that a widespread "inappropriate use" of N-95 masks was being observed, particularly those having valved respirators, by public other than designated healthcare workers. The DGHS has also referred to its advisory of using homemade protective coverings for…

21 Jul

Glenmark calls overpricing charge baseless- Fabiflu

editor0 CommentsBusinessGlenmark

In a strong-worded reaction to the Drugs Controller General of India (DCGI)'s move to pull up drug major Glenmark on charges of alleged overpricing, false and misleading claims related to its COVID-19 drug Favipiravir, the company has responded to the apex drug controller saying it was "dismayed" over the careless, unsubstantiated allegations that are devoid of merits. In a letter to DCGI V.G. Somani, Glenmark said compared to other therapies approved for emergency use in COVID-19 in India, FabiFlu is much more economical and an effective treatment option. The estimated total cost of therapy for full course is only Rs 9,150, when compared to the prices of Remdesivir (Rs…